APP Pharmaceuticals, Inc.
Fresenius Kabi Enters Into Licensing and Settlement Agreements with sanofi-aventis
Published in Healthcare Finance, Tax and Law Weekly, April 14th, 2010
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), the parent company of APP Pharmaceuticals, Inc., announced that APP and other Fresenius Kabi companies have entered into license and settlement agreements with sanofi-aventis covering patents that apply to Eloxatin® (oxaliplatin injection and oxaliplatin for injection). The agreements with sanofi-aventis resolve a patent infringement lawsuit, which was pending in the United States District Court for the District of New Jersey.
In 2007, APP and Fresenius Kabi filed ANDAs seeking approval to market generic oxaliplatin products. In response to these filings, sanofi-aventis filed lawsuits against APP and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Alternatives to Laboratory Animals
Research by J. Richmond and colleagues in alternatives to laboratory animals provides new insights - American Academy of Nurse Practitioners
Dr. Tay Kopanos Named AANP Director of Health Policy/State Government Affairs - American Civil Liberties Union of Illinois
Statement of Colleen K. Connell, Executive Director, American Civil - American College of Medical Genetics
American College of Medical Genetics Lauds Federal Court Ruling of - American Legislative Exchange Council
Illinois Is 40th State to Defend Health Care Choice; Oklahoma Health Freedom Bill Poised for Ballot - AmeriLithium Corp.
AmeriLithium Provides Corporate Update on Diversified Lithium Projects - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
